Table 2.
Markers and signature genes of HNSCC CAFs.
CAFs markers/ signature genes | Description of markers/ genes | Expression level in HNSCC CAFs | Biological functions/ notes | References |
---|---|---|---|---|
Vimentin | Type III intermediate filament protein | Upregulated | Promoting tumor EMT/ poor outcome | [70] |
α-SMA | Actin isoform | Upregulated | Related with CAFs activation/ poor outcome | [136] |
FSP1 | Calcium-binding protein containing 2 EF-hand calcium-binding motifs | Upregulated | Identifying CAFs in vitro | [70] |
FAP | Membrane-bound gelatinase | Upregulated | Poor outcome | [60, 136] |
PDGFRα | Protein tyrosine kinase receptor | Upregulated | Mediating mesenchymal stromal cell chemotaxis to tumor | [137] |
PDGFRβ | Protein tyrosine kinase receptor | Upregulated | Signing stromal activation in tumor | [60, 138] |
Caveolin-1 | Scaffolding protein within caveolar membranes | Upregulated | Inhibited the TGF-β/SMAD signaling and promoting CAFs activation | [134, 139] |
Periostin | Secreted extracellular matrix protein, a ligand for α-V/β-3 and α-V/β-5 integrins | Upregulated | Promoting tumor stemness/ poor outcome | [60, 85] |
Podoplanin | Mucin-type protein, heavily O-glycosylated glycoprotein | There is no relationship directly | Promoting lymph nodes metastasis/ poor outcome | [140] |
CD44 | Non-kinase transmembrane glycoprotein | Upregulated | Mediating immunosuppression/ poor outcome | [141] |
AKT3 | A serine/ threonine protein kinas that modulates various cellular responses via the PI3K-AKT pathway | Upregulated | Mediating immunosuppression and promoting myofibroblastic phenotype/ poor outcome | [60] |
COX-2 | An inducible enzyme responsible for the production of prostaglandins at sites of inflammation and wound‐healing. | Upregulated | Promoting tumor migration, angiogenesis and invasiveness/ poor outcome | [95, 125] |